Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis

26 References
  • AKASHI Naotsugu
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • MATSUMOTO Isao
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • TANAKA Yoko
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • INOUE Asuka
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • YAMAMOTO Kayo
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • UMEDA Naoto
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • TANAKA Yuki
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • HAYASHI Taichi
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • GOTO Daisuke
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • ITO Satoshi
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • SEKIGUCHI Kaneo
    Translational Sciences Department, Development Division, Novartis Pharma K. K.
  • SUMIDA Takayuki
    Clinical Immunology, Advanced Biochemical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba

Search this article

Journal

References(26)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top